Secukinumab Rapidly Improves Disease Severity in Mild to Moderate Psoriasis - HCPLive

Retrieved on: 2023-10-22 18:48:10

Tags for this article:

Click the tags to see associated articles and topics

Secukinumab Rapidly Improves Disease Severity in Mild to Moderate Psoriasis - HCPLive. View article details on hiswai:

Excerpt

The drug, a fully human monoclonal antibody designed to selective neutralize interleukin (IL)-17A, has previously demonstrated long-term efficacy ...

Article found on: www.hcplive.com